BIOTECH100
A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

Bioenvision

About Bioenvision:

Bioenvision is a product-focused biopharmaceutical company with two approved cancer therapeutics. The FDA recently approved their lead cancer product, clofarabine, for the treatment of pediatric acute lymphoblastic leukemia, or ALL.Genzyme Corporation, their co-development partner, currently holds marketing rights in the U.S. and Canada for clofarabine for all cancer indications and controls U.S. development of clofarabine in these indications. Genzyme is marketing clofarabine under the brand name Clolar in the U.S.

Modrenal is approved in the U.K. for the treatment of post-menopausal advanced breast cancer following relapse to initial hormone therapy.

 

Pipeline info Bioenvision

 

ModrenalProstate Cancer
VirostatChronic Hepatitis C
Clofarabine (CLOLAR) Solid Tumors

 

 

More on Bioenvision:

Home Page

Key Statistics for Bioenvision

Basic Chart for Bioenvision

Analyst Opinion

Analysts Estimates

News Headlines

 
Biotech100 Index
What are the Requirements to be listed in the Biotech100 Index?
See the Biotech100 List

Sponsored Links

Clinical Trials
What is a Clinical Trial?
Phase I ,-- Phase II, -- PhaseIII
What is Randomized Control?
 What is a Double Blind Experiment?
What is the role of the FDA?

 

Key Biotech Terms

 

Biotech Resources

 

Investing in Stocks
Small Cap Stocks
Stocks and Bonds
Biotech100 Index

Careers and Employment
Biotechnology and Pharmaceutical
What are the Fastest Growing Careers?

 

Google
 
Web www.biotech100.com
SEARCH THE BIOTECH100 WEBSITE
  
     

 


Copyright 2005 BIOTECH100.COM. All rights reserved.

email: info@biotech100.com